M. Flodstrom et Dl. Eizirik, INTERFERON-GAMMA-INDUCED INTERFERON REGULATORY FACTOR-I (IRF-1) EXPRESSION IN RODENT AND HUMAN ISLET CELLS PRECEDES NITRIC-OXIDE PRODUCTION, Endocrinology, 138(7), 1997, pp. 2747-2753
The radical nitric oxide (NO) may be a mediator of beta-cell damage in
IDDM. The cytokines IFN-alpha and IL-1 beta are required for expressi
on of the enzyme nitric oxide synthase (iNOS), and NO production by hu
man pancreatic islets. In this study, possible mechanisms by which IFN
-gamma participates in iNOS messenger RNA (mRNA) expression were evalu
ated in both rodent and human islets cells. Addition of IFN-gamma, bef
ore or after arrest of IL-1 beta-induced iNOS gene transcription by ac
tinomycin D, did not prolong iNOS mRNA halflife in the rat insulin-pro
ducing cell line RINm5F (RIN cells). IFN-gamma also failed to modify I
L-1 beta-induced activation of the transcription factor kappa B (NF-ka
ppa B) in RIN cells, as determined by electrophoretic mobility shift a
ssay. However, IFN-gamma induced an early (30 min-1 h) increase in int
erferon regulatory factor-1 (IRF-1) mRNA expression and a later (2 h)
19-fold increase in RIN cell nuclear IRF-1 protein content, an effect
further potentiated by IL-1 beta. The total cellular content of IRF-1
protein increased by 30- to 50-fold in human islets exposed for 2-8 h
to IFN-gamma or IFN-beta + IL-1 beta. IL-1 beta alone induced a margin
al and transient increase in IRF-1. It has been previously reported th
at nicotinamide prevents IL-1 beta-induced IRF-1 expression in rat pan
creatic islets. However, nicotinamide (20 mM) presently failed to prev
ent IL-1 beta + IFN-beta-induced IRF-1 protein expression in human pan
creatic islets. In conclusion, the effects of IFN-gamma on iNOS expres
sion can neither be explained by iNOS mRNA stabilization nor increased
NF-kappa B activation. However, IFN-gamma induces an early increase i
n cellular IRF-1 content, and this may contribute to increased iNOS mR
NA expression.